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HORMESIS FOR FINE PARTICULATE MATTER (PM 2.5)
Louis Anthony (Tony) Cox, Jr.  Cox Associates, University of Colorado
 The hypothesis of hormesis – that substances that harm health at high exposures can
reduce risks below background at low exposures, e.g., if they activate defenses without
overwhelming them – becomes important for practical policy making if it holds for regu-
lated substances. Recently, the U.S. EPA concluded that reductions in ambient concentra-
tions of fine particulate matter (PM2.5) in air caused trillions of dollars worth of human
health benefits for a compliance cost of only about $65 billion per year. This conclusion
depends on an unverified assumption of a positive, causal, straight-line relation between
PM2.5 concentrations and mortality risks. We review empirical data on PM2.5 and mor-
tality risks (and their precursors, inflammatory responses) and conclude that the PM2.5
concentration-response relation may be J-shaped, rather than linear. This possibility
implies that the 1990 Clean Air Act Amendment may well have produced no (or negative)
human health benefits, rather than the trillions of dollars worth of reduced mortalities
ascribed to it by EPA; and that attempts to achieve further risk-reduction benefits by fur-
ther reducing PM2.5 concentrations may be counterproductive. This creates a very high
value for scientific information that better reveals the true shape of the PM2.5 concentra-
tion-response function at and below current ambient levels.
Key words: PM2.5, hormesis, Clean Air Act, air pollution health effects, uncertainty analysis, risk-
cost-benefit analysis, Weibull uncertainty distribution
INTRODUCTION
A strong form of the hypothesis of hormesis in toxicology and disease
biology states that exposures to sufficiently small concentrations or expo-
sure rates of agents that cause harm at higher levels are typically benefi-
cial, reducing rates of disease or adverse effects below their background
levels. A commonly postulated and observed general mechanism for
hormesis is that low levels of exposure activate defensive mechanisms
without overwhelming them, while higher levels saturate, deplete, or
down-regulate the defenses, causing injury. For example, studies of the
etiology of lung injury and diseases resulting from exposures to particu-
lates in air have shown that high, prolonged exposures to a variety of par-
ticulates induce a non-specific inflammatory response, characterized by
an increase in production of reactive oxygen species (ROS) by alveolar
macrophages and other lung cells (Janssen et al. 1992, Comhair and
Erzurum 2002, Azad et al. 2008). Low levels of exposure stimulate a com-
pensating production of antioxidants (Janssen et al. 1992, Comhair and
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Erzurum 2002) that may compensate – or, if hormesis is correct, more
than compensate – for increased ROS production, but experiments in
rats show that higher levels of exposure overwhelm and down-regulate
this limited defensive capacity, shifting the balance of oxidants and
antioxidants toward an abnormally high-ROS environment that may then
increase the risks of a variety of lung diseases, from emphysema to lung
cancer (Azad et al. 2008). Such a mechanistic account naturally suggests
that the concentration-response (C-R) function for particulate matter
(PM) may have an effective threshold, or a hormetic (U-shaped or J-
shaped) shape with a nadir, below which further reductions in exposure
concentration, C, do not produce further reductions (and may even
increase) the rates of adverse health responses, R.
If the hypothesis of hormesis is to play an important role in inform-
ing and improving national science-policy decisions about risk manage-
ment of low-concentration exposures, it must be evaluated in the context
of important real-world risk assessments and risk management decisions.
A recent assessment by the United States Environmental Protection
Agency (EPA) concluded that further reductions in fine particulate mat-
ter (PM2.5) in air are certain to produce further reductions in mortality
risks (EPA, 2011) – more specifically, by an amount described by a
Weibull uncertainty distribution, which puts zero probability mass on
zero and negative values for the slope of the concentration-response rela-
tion at low exposure concentrations. This assessment provides an ideal
opportunity to examine the plausibility of hormesis for PM2.5. EPA’s
analysis assumes that the C-R relation between PM2.5 concentrations (C)
and mortality risks (R) is well described at low (e.g., present and future)
ambient exposure levels by a straight-line, no-threshold function all the
way down to the lowest measurable levels. According to this assumption,
the C-R relation can be characterized by a single number, the slope of this
line, called the C-R coefficient. EPA’s uncertainty analysis puts a subjec-
tive probability of 100% on positive values for the C-R coefficient, imply-
ing that hormesis has zero probability of correctly describing the C-R
function for PM2.5. The purpose of this paper is to re-examine this
assumption in light of available data, and to re-evaluate whether horme-
sis might after all give a correct description of the PM2.5 C-R data.
If hormesis turns out to provide a correct description, or even a plau-
sible possibility, for PM2.5, it has crucially important policy implications.
Instead of accepting EPA’s assumption that further reductions in PM2.5
concentrations will necessarily produce (proportionate) reductions in
mortality risks and gains in life expectancy, hormesis would imply that
there is an optimal exposure level (which we might have already passed)
below which further reductions in PM2.5 concentrations produce no
additional gains in public health – let alone the trillions of dollars of
health benefits per year projected by EPA. Indeed, at sufficiently low
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ambient concentrations, further reductions in PM2.5 could even be asso-
ciated with modest increases in mortality rates, implying a negative C-R
relation. This would require rethinking the wisdom and prudence of con-
tinuing to spend resources (estimated by EPA as about $65 billion per
year in compliance costs) to reduce PM2.5 concentrations in order to
seek hypothesized health benefits that may only become more remote as
they are pursued.
META-ANALYSIS OF PM2.5-MORTALITY STUDIES SHOWS BOTH
POSITIVE AND NEGATIVE ASSOCIATIONS, SUGGESTING A POSSIBLE J-
SHAPED RELATION
Over 100 epidemiological studies have now estimated the concentra-
tion-response (C-R) coefficient in regression models of all-cause and
cause-specific mortality rates regressed against ambient PM2.5 concen-
trations and other covariates. A puzzling feature of these studies has been
that a sizable minority of them report statistically significant negative C-R
coefficients, i.e., higher concentrations of PM2.5 are associated with sig-
nificantly lower mortality rates, even though more report statistically sig-
nificant positive coefficients. Nearly a decade ago, Dominici et al. (2002)
found 20 non-significant negative C-R coefficients among 88 cities,
although most coefficients in that study (positive and negative) were not
statistically significant, due to limitations in sample sizes. Thus, the nega-
tive coefficients might have been due to sampling error. However, a more
recent review (Franklin et al. 2007) found negative C-R coefficients for all-
cause mortality and PM2.5 in one third (9 of 27) U.S. communities, with
several being statistically significant (including Birmingham, Dallas, and
Houston). Although it has been common practice to simply pool results
across locations, and to conclude that the pooled mean C-R coefficient is
significantly positive (since the 2/3 majority of positive coefficients out-
weighs the 1/3 of negative ones), this does not resolve the puzzle of why
so many locations report negative coefficients.
If the statistical models being used are even approximately correct,
then finding multiple statistically significant negative coefficients among
27 locations suggests that negative associations between PM2.5 and mor-
tality rates really do occur. The same logic suggests that the multiple sig-
nificant positive coefficients are also real. To reconcile these opposing
conclusions, it is natural to assume that they are two parts of a larger, non-
monotonic relation, e.g., a J-shaped or U-shaped function, with ascending
and descending segments. In this case, locations with a high proportion
of exposures on the descending part of the C-R relation will have nega-
tive average C-R coefficients, while locations with a high proportion of
exposures on the ascending portion will have positive average C-R coeffi-
cients. Averaging the C-R coefficients across locations is not sensible, how-
ever, if the response to changes in concentrations is highly location-spe-
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cific – as, indeed, appears to be the case. For example, an examination of
C-R curves (rather than assumed constant C-R slope coefficients) for
PM10 data in the twenty largest U.S. cities identified U-shaped curves in
some cities, although this information was lost when the curved were
averaged across cities (Daniels et al. 2000).
EPIDEMIOLOGICAL DATA ARE AMBIGUOUS, BUT NOT INCONSISTENT
WITH HORMESIS
Evidence for negative, as well as positive, association between PM2.5
concentrations and mortality rates also arises from analyses that take into
account model uncertainty by considering multiple plausible models, rather
than selecting any single model (which would almost certainly be incor-
rect, given the large number of alternative statistical models that fit the
data approximately equally well). Bayesian Model-Averaging (BMA) is
one of the best-developed of such “ensemble” methods for using multiple
models to reduce model-selection biases and to make more accurate risk
predictions and uncertainty characterizations than any single regression
model is likely to achieve. Applied to data from 11 Canadian cities, BMA
indicates that both total suspended particulate (TSP) and ozone have sta-
tistically significant negative associations with mortality rates (Koop et al.
2007). Similar findings of negative associations for ozone have been
reported in the United States (Joseph 2008).
To independently check the validity of such previously published
reports of negative C-R relations, one may examine the iHAPSS (internet-
based Health and Air Pollution Surveillance System) data base of pollu-
tant levels and mortality rates for U.S. cities made available on-line by
Johns Hopkins at www.ihapss.jhsph.edu/. Figure 1 shows plots of cause-
specific mortality rate vs. deciles of estimated PM2.5 concentrations. (The
data are reconstructed from preprocessed NMMAPS data posted at the
website, which documents the smoothing procedure used to preprocess
the raw data and the resulting possibility of negative values when data are
reconstructed by adding back the smoothed mean. The NMMAPS docu-
mentation defines all-cause mortality (death) as excluding accidents.) The
plots pool data across time (daily data from 1987 to 2000, although dif-
ferent cities started reporting in different years) and across the ten largest
metropolitan area in the data base (Chicago, Dallas/Fortworth, Detroit,
Houston, LA, Miami, New York, Phoenix, San Diego, and Santa
Ana/Anaheim.)
The plots do not suggest any significant positive relations between
PM2.5 and excess mortality risk at the lowest exposure concentrations
(except possibly for COPD, which is a relatively small contributor to death
rates); if anything, they are consistent with a weak negative or U-shaped
association between exposures and cause-specific mortality risks for car-
diovascular disease (CVD) and pneumonia/influenza mortality risks at the
L. A. Cox, Jr.
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low (left) end of the PM2.5 exposure concentration distribution. The
highest (right-most) deciles of the PM2.5 exposure concentration distri-
bution do show increased risks, but it would be inappropriate to extrapo-
late these linearly down to zero, given the U-shapes of the empirical C-R
relations between exposure concentrations (C) and mortality rates (R).
In multivariate regression analyses, other explanatory variables in the
date set (especially year, month of year (with the winter months of
December-February being high-risk months as well as high-pollution
months), and minimum temperature) are all highly statistically significant
predictors of all-cause and cardiovascular disease mortality rates in differ-
ent age categories. PM2.5, too, is a strong predictor of all-cause and CVD
mortality rates. After conditioning on other variables, however, no positive
statistical effect of PM2.5 on mortality rates remains. For example, Table 1
shows the results of a multiple linear regression model fit to the data
(using the commercial statistical software environment Statistica 9.0. The b
coefficients are the ordinary least squares regression coefficients, and the
b* coefficient are their standardized values. The variable Dec-Feb is a bina-
ry variable with value 1 for these three months and 0 for other months.)
Both estimated PM2.5 exposure (pm25Reconstruct) and all-cause mortality
rates are highest in the winter months: the variable Dec-Feb is a con-
Hormesis for Fine Particulate Matter
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FIGURE 1. PM2.5 and Mortality Rate C-R Relations in Ten U.S. Cities. C-R relations for annual mor-
tality rates: A = cardiovascular disease (CVD); B = pneumonia (pne) and pneumonia/influenza
(pneuinf); C = all-case (death), chronic obstructive pulmonary disease (COPD), and respiratory
(resp); D = all-cause mortality (expanded from C). 
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founder that explains a positive univariate association between them, as
shown in Figure 1D. However, in the multivariate model in Table 1, the
coefficient of PM2.5 exposure is significantly negative, suggesting that,
apart from such confounding, PM2.5 exposure does not increase mortali-
ty rates. Although, any such ecological regression (with unknown individ-
ual exposures) must be interpreted with caution, it is noteworthy that the
apparent positive association between PM2.5 and mortality in Figure 1D is
entirely removed by controlling for other variables in multivariate analysis,
leaving a negative association at sufficiently low exposure concentration
(and hence hormesis, overall) as a viable possibility.
Table 2 shows analogous results specifically for CVD mortality rates.
Although both all-cause and CVD mortality rates are significantly pre-
dicted by month of year, as well as year (as mortality rates fall and life
expectancies rise over time), minimum temperature (tmin), and propor-
tion of Hispanics in the population, it is conspicuous that PM2.5 (the
pm25reconstruct variable) has no significant positive relation with either
mortality rate. The same is true in non-linear (e.g., polynomial regression
and classification tree) models with interaction effects, for lagged values
of PM2.5, and for other health end points, including respiratory mortali-
ty rate: PM2.5 at ambient levels is not significantly positively associated with any
adverse health outcomes. This observation for ten U.S. cities is generally con-
sistent with the results of Koop and Tole (2004) for Toronto.
Although reports of mixed positive and negative associations of
PM2.5 concentrations with mortality rates are common in the literature
(Daniels et al. 2000, Franklin et al. 2007, Koop et al. 2007, Joseph 2008),
and although they may suggest a possible U-shaped or J-shaped relation
between exposure concentrations and mortality rates, epidemiological
studies are generally too weak and ambiguous to decisively reveal the true
shape of the concentration-response function. Principal reasons include
the lack of reliable measurements of individual exposures and lack of
complete identification and control of confounders, both of which cast
L. A. Cox, Jr.
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TABLE 1. Multiple Linear Regression Model for All-Cause Mortality Rates in 10 Cities 
Regression Summary for Dependent Variable: death (all causes)
R= .41 R?= .17 Adjusted R?= .17
Std.Err. Std.Err. 
N=22242 b* of b* b of b t(22235) p-value
Dec-Feb 0.16 0.007 31.66 1.50 21.2 0.000000
tmin 0.15 0.008 0.83 0.04 20.0 0.000000
Year 0.02 0.006 0.35 0.14 2.6 0.009320
Month -0.02 0.006 -0.47 0.16 -3.0 0.002524
pm25Reconstruct -0.02 0.006 -0.18 0.05 -3.4 0.000589
pHisp -0.43 0.007 -226.40 3.47 -65.3 0.000000
Intercept -619.44 270.48 -2.3 0.022023
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severe doubt on statistical estimates and inferences obtained by plugging
estimated city-level exposures into regression or time series models as pre-
sumed explanatory variables (Sheppard et al. 2011). In addition, statisti-
cal associations (of any sign) need not necessarily reflect causality.
Therefore, is desirable to consider toxicological dose-response data, to
see whether a J-shaped relation is consistent with experimental data.
EXPERIMENTAL DATA SHOW J-SHAPED CONCENTRATION-RESPONSE
RELATIONS
Experimental studies in human volunteers, including asthmatics,
have led some commentators to conclude that, “[T]he weight of the evi-
dence from controlled studies with animals and human volunteers sug-
gests that PM is unlikely to cause premature death or other serious health
effects at levels found in real-world air” (Schwartz 2007). This is consis-
tent with earlier conclusions that, “It remains the case that no form of
ambient PM — other than viruses, bacteria, and biochemical antigens —
has been shown, experimentally or clinically, to cause disease or death at
concentrations remotely close to US ambient levels” (Green and
Armstrong 2003). To test such reassuring-looking conclusions more care-
fully, it is instructive to examine the concentration-response relations for
particulate matter in animals, where concentrations have been varied sys-
tematically from low levels, at which no adverse effects are observed, to
much higher levels at which inflammation in mice and rats, and fibrosis
and lung tumors in rats, can be induced.
Figure 2 summarizes two sets of experimental data. The left panel
shows lung tumor responses in rats (the only species that develops them)
in response to varying concentrations of different types of particulates.
The mechanism of tumor induction involves overwhelming of antioxi-
dant and clearance defenses, unresolved chronic inflammation, repeti-
tive injury to lung tissue, and fibrosis, scarring, and proliferation leading
to tumors (Azad et al. 2008, Oberdörster 1997). The three right panels
Hormesis for Fine Particulate Matter
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TABLE 2. Multiple Linear Regression Model for Cardiovascular Mortality Rate 
Regression Summary for Dependent Variable: cvd
R= .37 R?= .14 Adjusted R?= .14
Std.Err. Std.Err. 
N=22242 b* of b* b of b t(22235) p-value
Dec-Feb 0.14 0.01 15.53 0.85 18.2 0.000000
tmin 0.12 0.01 0.36 0.02 15.0 0.000000
pm25Reconstruct -0.01 0.01 -0.06 0.03 -1.8 0.068621
Month -0.02 0.01 -0.22 0.09 -2.4 0.016366
Year -0.05 0.01 -0.56 0.08 -7.3 0.000000
pHisp -0.38 0.01 -110.64 1.98 -55.8 0.000000
Intercept 1170.99 154.60 7.6 0.000000
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show the responses of three inflammatory markers in mice, to different
concentrations of ultrafine carbon particulates (ufCP).
In both experiments, the surface area of particles in the lung is used
as a dose metric, since it is the best predictor of response (better than
mass or volume of PM. The “BET” protocol referred to on the right side
provides a way to quantify this surface area.) The original authors of these
experimental studies interpreted their findings as showing a threshold
exposure level, below which exposure did not increase risk of adverse
responses (inflammation in mice, on the right; tumors in rats, resulting
from unresolved inflammation and associated other effects, on the left).
However, as indicated by the J-shaped cuves that we have superimposed
on the data points, the data are actually more consistent with hormesis,
i.e., a positive baseline level at zero exposure that is reduced by very low
levels of exposure, but that increases above background at higher expo-
sure concentrations. Thus, while there may indeed be an exposure con-
centration level below which risk of adverse effects is not greater than
background, it is more accurate to interpret the J-shaped curves as indi-
cating hormesis, rather than thresholds.
DISCUSSION AND CONCLUSIONS
EPA’s assumption that the concentration-response (C-R) function
relating changes in ambient exposure concentrations of fine particulate
matter (PM2.5) is well-described by a straight line with a positive slope
(with 100% confidence, based on a subjective Weibull uncertainty analy-
sis that precludes zero and negative slopes from having positive subjective
probabilities), poses a direct challenge to the hypothesis of hormesis. We
have reexamined empirical evidence on the shape of the C-R function,
and find that such certainty that a positive linear C-R relation provides a
L. A. Cox, Jr.
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FIGURE 2. Rat tumor (left-most) and mouse inflammation (right) responses to PM. Original figures
reproduced with permission from Environmental Health Perspectives, www.ncbi.nlm.nih.gov/pmc/arti-
cles/PMC1392224/figure/f3-ehp0114-000328/, doi: 10.1289/ehp.8266 and www.ncbi.nlm.nih.gov/
pmc/articles/PMC1470142/?tool=pubmed. J-shaped curves have been superimposed on the original
figures. 
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better description that alternative, hormetic (J-shaped) relations is unjus-
tified. A J-shaped relation provides one possible explanation for common
reports in the literature of statistically significant negative, as well as pos-
itive, C-R coefficients. However, in the absence of more accurate and
detailed information about individual exposures, as opposed to ambient
exposures at monitoring locations, epidemiological data alone cannot
decisively establish the true shape of the C-R function (Sheppard et al.
2011). In our own analysis of a data set made available for public analysis,
there is no clear positive relation between PM2.5 and all-cause or cause-
specific mortality rates, although cause-specific mortality rates are signifi-
cantly correlated with each other.
Turning to toxicological data, the results are clearer: in animal stud-
ies with accurate exposure measurements for individual animals, it is
clear that inflammatory responses (and tumors in rat lungs) are not
increased by sufficiently low exposures, contrary to the low-dose linear
no-threshold assumption. As shown in Figure 2, hormesis (J-shaped dose-
response relations) provides a description of such data.
In conclusion, available evidence supports the hypothesis of hormesis
more strongly than the hypothesis of a positive linear no-threshold model
for PM2.5 and mortality risks. Experimental evidence (Figure 2) indicates
hormesis as the hypothesis that best fits the data. Epidemiological data,
although more ambiguous (Figure 1), is consistent with hormesis in meta-
analyses, as evidenced by mixed positive and negative C-R coefficients.
However, it is not necessary to settle conclusively whether hormesis
holds for PM2.5 in order for it to have major policy implications. Recent
EPA estimates of the human health benefits from the 1990 Clean Air Act
Amendment (EPA, 2011) are crucially dependent on the unverified
assumption of a positive linear no-threshold C-R function for PM2.5. As
soon as it is acknowledged that hormesis is at least a plausible possibility
– so that assigning it a subjective probability of zero, as in EPA’s benefit
assessment, is not warranted by data – it follows that the true incremental
human health benefits of the 1990 Clean Air Act Amendment could also
be zero or negative in many locations. This changes the nature of the
cost-benefit comparison presented to the public from an apparent cer-
tainty of large positive return, in which compliance costs of $65 billion
per year are said to produce lower mortality risks among the elderly, val-
ued by EPA at about two trillion dollars per year, to a revised comparison
in which the expenditure of $65 billion per year in compliance costs may
instead – with probability of greater than 50%, if hormesis is more plau-
sible than low-dose linearity – produce zero or negative net health bene-
fits in reducing mortality risks. Many policy-makers who would embrace
the former description might reject the latter, or at least request much
more information about the uncertainties and evidence on the shape of
the C-R function for PM2.5 at and below current ambient levels.
Hormesis for Fine Particulate Matter
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Thus, the hypothesis of hormesis, which appears to be supported by
experimental data and consistent with (but not decisively proved or refut-
ed by) current epidemiological data, changes the policy evaluation of
claimed marginal health benefits of the 1990 Clean Air Act Amendment
from a clear win for the public to a possible loss. More careful evaluation
of the true shape of the C-R function is needed to determine which is cor-
rect. However, that the hypothesis of hormesis is plausible for a major air
pollutant such as PM2.5 already provides sufficient grounds to question
regulatory benefits assessments, evaluations, and policies that assume that
cleaner air necessarily reduces mortality risks, even at and below current
ambient concentrations.
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